Number (%) of patients with the most common adverse events during the treatment period (whether or not drug related, >3%)
| Adverse event | Tegaserod (n (%)) | Placebo (n (%)) |
|---|---|---|
| Headache | 31 (12.0) | 29 (11.1) |
| Diarrhoea | 26 (10.0) | 8 (3.1) |
| Abdominal pain (not specified) | 15 (5.8) | 8 (3.1) |
| Upper respiratory tract infection | 15 (5.8) | 20 (7.7) |
| Nausea | 11 (4.2) | 9 (3.4) |
| Dizziness | 10 (3.9) | 9 (3.4) |
| Pyrexia | 9 (3.5) | 4 (1.5) |
| Nasopharyngitis | 7 (2.7) | 8 (3.1) |
| Abdominal distension | 6 (2.3) | 8 (3.1) |
| Abdominal pain, upper | 6 (2.3) | 11 (4.2) |